Camber Capital Management LP
CIK 1444043 · View on SEC EDGAR ↗
- Portfolio value
- $1.1B
- Positions
- 25
- As of
- June 30, 2025 Data as of Q2 2025
#2,347 of 9,443 by 13F value · top 24.9%
Portfolio value QoQ: -62.2% 13F does not disclose cash
- Top 10 holdings weight
- 79.25%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 18
- Effective number of positions
- 8.3
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2025: 6.94% Est. buys $134,622,500 · sells $1,696,327,370
- New positions
- 4
- Increased
- 1
- Decreased
- 17
- Closed
- 10
Put-notional exposure: 29.0% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Sector breakdown
Health Care
71.0%
Other/Unmapped
29.0%
Full portfolio 25 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| SPY SPY | $308,925,000 | 29.00% | 500,000 | Put option | $-530,160,000 | Down ×2 | |
| ZBH Zimmer Biomet Holdings, Inc. Common Stock | $91,210,000 | 8.56% | 1,000,000 | $-163,445,000 | Down ×1 | ||
| BAX Baxter International Inc. Common Stock | $86,298,000 | 8.10% | 2,850,000 | $-110,524,500 | Down ×1 | ||
| HUM Humana Inc. Common Stock | $73,344,000 | 6.89% | 300,000 | $-118,491,000 | Down ×1 | ||
| CVS CVS Health Corporation Common Stock | $72,429,000 | 6.80% | 1,050,000 | $-80,008,500 | Down ×2 | ||
| GMED Globus Medical, Inc. Class A Common Stock | $47,216,000 | 4.43% | 800,000 | $-44,284,000 | Down ×1 | ||
| ICLR ICON plc - Ordinary Shares | $43,635,000 | 4.10% | 300,000 | Up ×1 | |||
| ASND Ascendis Pharma A/S - American Depositary Shares | $43,150,000 | 4.05% | 250,000 | $-11,401,000 | Down ×2 | ||
| MRK Merck & Company, Inc. Common Stock (new) | $39,580,000 | 3.72% | 500,000 | Up ×1 | |||
| GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares) | $38,400,000 | 3.60% | 1,000,000 | Call option | $-340,000 | ||
| PFE Pfizer, Inc. Common Stock | $36,360,000 | 3.41% | 1,500,000 | $-26,990,000 | Down ×2 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $32,982,000 | 3.10% | 600,000 | $-2,363,000 | Up ×2 | ||
| UNH UnitedHealth Group Incorporated Common Stock (DE) | $31,197,000 | 2.93% | 100,000 | Up ×1 | |||
| VTRS Viatris Inc. - Common Stock | $24,557,500 | 2.31% | 2,750,000 | $-40,767,500 | Down ×2 | ||
| BKD Brookdale Senior Living Inc. Common Stock | $14,964,000 | 1.40% | 2,150,000 | $-24,161,000 | Down ×2 | ||
| ZIMV ZimVie Inc. - Common Stock | $14,960,000 | 1.40% | 1,600,000 | $-5,398,000 | Down ×2 | ||
| APLS Apellis Pharmaceuticals, Inc. - Common Stock | $14,713,500 | 1.38% | 850,000 | Up ×1 | |||
| MYGN Myriad Genetics, Inc. - Common Stock | $10,620,000 | 1.00% | 2,000,000 | $-10,224,500 | Down ×2 | ||
| EVH Evolent Health, Inc Class A Common Stock | $9,571,000 | 0.90% | 850,000 | $-18,839,000 | Down ×2 | ||
| CON Concentra Group Holdings Parent, Inc. Common Stock | $8,228,000 | 0.77% | 400,000 | $-26,492,000 | Down ×2 | ||
| INGN Inogen, Inc - Common Stock | $6,854,250 | 0.64% | 975,000 | $-97,500 | |||
| DNLI Denali Therapeutics Inc. - Common Stock | $5,596,000 | 0.53% | 400,000 | $-11,397,750 | Down ×2 | ||
| TBPH Theravance Biopharma, Inc. - Ordinary Shares | $4,963,500 | 0.47% | 450,000 | $-3,966,500 | Down ×1 | ||
| ANAB AnaptysBio, Inc. - Common Stock | $2,775,000 | 0.26% | 125,000 | $-11,167,500 | Down ×2 | ||
| OSUR OraSure Technologies, Inc. - Common Stock | $2,700,000 | 0.25% | 900,000 | $-333,000 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| XBI | June 30, 2025 | 2,000,000 | $162,200,000 | No longer tracked |
| PTCT | June 30, 2025 | 1,500,000 | $76,440,000 | 44.6% |
| CI | June 30, 2025 | 200,000 | $65,800,000 | -16.3% |
| QGENXXXX | June 30, 2025 | 1,400,000 | $56,210,000 | No longer tracked |
| SRPT | June 30, 2025 | 800,000 | $51,056,000 | 14.4% |
| IONS | June 30, 2025 | 725,000 | $21,873,250 | 51.6% |
| MLTX | June 30, 2025 | 441,000 | $17,229,870 | -66.4% |
| TXG | June 30, 2025 | 1,000,000 | $8,730,000 | 438.1% |
| GPCR | June 30, 2025 | 300,000 | $5,193,000 | 145.2% |
| GMAB | June 30, 2025 | 50,000 | $979,000 | 62.3% |
| MDT | March 31, 2025 | 2,750,000 | $219,670 | 2.5% |
| JAZZ | March 31, 2025 | 1,150,000 | $141,623 | 101.7% |
| ALKS | March 31, 2025 | 1,500,000 | $43,140 | 45.6% |
| MEDP | March 31, 2025 | 125,000 | $41,529 | 99.9% |
| HLF | March 31, 2025 | 3,000,000 | $20,070 | 41.7% |
| BKDT | March 31, 2025 | 250,000 | $17,248 | No longer tracked |
| MRUS | March 31, 2025 | 250,000 | $10,513 | No longer tracked |